Vine Health’s platform uses behavioural science and AI to increase the survival of cancer patients.

Patient behaviours account for up to 50% of their medical outcome; more than their clinical care and genetics combined.

Vine Health’s AI-driven technology enables cancer patients to track, understand and optimise their own health through personalised behavioural nudges.

Vine Health’s current distribution pipeline through hospitals and clinics provides them with access to over 1 million cancer patients.

Through this platform, they gather highly contextual real-world data that enables pharmaceutical companies to accelerate drug trial and licensing processes, and to access higher reimbursements.